SANUWAVE Health Inc (NAS:SNWV)
$ 6.4 -0.10 (-1.54%) Market Cap: 55.03 Mil Enterprise Value: 66.42 Mil PE Ratio: 19.39 PB Ratio: 30.48 GF Score: 34/100

Preliminary Q3 2025 SANUWAVE Health Inc Earnings Call Transcript

Oct 06, 2025 / 09:30PM GMT
Release Date Price: $40.82 (+9.06%)

Key Points

Positve
  • SANUWAVE Health Inc (SNWV) reported record quarterly revenues of $11.4 million to $11.6 million, marking a 12% to 14% sequential growth from Q2 and 22% to 24% growth compared to the same quarter last year.
  • The company achieved a record number of system sales in Q3, with 155 systems placed during the quarter.
  • September was the best single month in company history for revenue, system sales, and applicators, indicating strong momentum towards the end of the quarter.
  • The company is experiencing significant growth in the mobile wound care space and is focusing on expanding into the hospital market, particularly targeting hospital-acquired pressure injuries (HAPI), a $22 billion market in the U.S.
  • SANUWAVE Health Inc (SNWV) is engaging with larger, more sophisticated customers, which is expected to lead to future growth opportunities and the development of evidence-based protocols in wound care.
Negative
  • The company did not meet its previously announced revenue guidance of $12 million to $12.7 million for Q3, citing challenges and disruptions in the market.
  • Uncertainty in the market, particularly regarding proposed changes in reimbursement for skin substitute and allograft products, led to a slow start in Q3, impacting overall performance.
  • Annual revenue guidance has been adjusted downward to $44 million to $46 million from the prior guidance of $48 million to $50 million.
  • The company is still in a ramp-up phase, with 10 out of 13 salespeople having joined since last November, indicating potential challenges in achieving immediate sales targets.
  • There is a lack of visibility into the exact types of wounds being treated, which could impact the company's ability to tailor its products and services effectively.
Operator

Good day, everyone, and welcome to the SANUWAVE Q3 Revenue Update. (Operator Instructions) Please note today's call will be recorded. (Operator Instructions)

It is now my pleasure to turn today's conference over to Morgan Frank, CEO.

Morgan Frank
SANUWAVE Health Inc - Chairman of the Board, Chief Executive Officer

Thank you very much. Welcome to SANUWAVE's Third Quarter 2025 Revenue Pre-announcement Call. Our press release on this went out earlier this afternoon. Joining me on the call is Peter Sorensen, our CFO. And after the presentation, we will open the call up to Q&A.

So we'll begin with the always riveting forward-looking statements and other disclosures. This call may contain forward-looking statements such as statements relating to future financial results, production expectations and plans for future business development activities. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot